Navigation Links
C-myc required by the immune system

c-myc, a gene commonly involved in cancer onset, has been found to have a role in the immune system's normal function according to a study published today in Blood. The surprising finding, by a Swiss research team led by investigators from the Lausanne Branch of the international Ludwig Institute for Cancer Research (LICR), showed that c-myc functions in the immune system's 'memory' of previous infections.

In order to rapidly and efficiently respond to new infections, the immune system evolved such that it stores a 'memory' of previous attack by pathogens. The specialized cells involved in this process are known as 'T memory cells'. The T memory cells are normally maintained at a low level that can be rapidly expanded if the pathogen is detected again. The maintenance of normal, low levels, or 'homeostasis', of T memory cells is dependent on a signalling factor, a so-called cytokine, known as 'IL- 15.

"Very little is known about the signalling pathways that actually control IL-15-dependent homeostasis," explains LICR's Dr. H. Robson MacDonald, the senior author of the study. "By analyzing genetically engineered mouse models with reduced c-myc, reduced IL-15 or absent IL-15, we discovered that it's actually c-myc, which is known primarily as an oncogene, that acts downstream of the IL-15 signaling pathway to regulate T memory cell homeostasis."

According to Dr. MacDonald, the study is basic research that may have implications for therapies of the future. "Understanding how immune memory works might allow us to improve therapeutic vaccines against, say, malaria or cancer. The unexpected finding is that this study is also a cautionary tale. Before we design new therapies that inactivate a gene product, which is an approach being considered for c-myc in cancer, we need to be very sure that we are not going to be also destroying a vital role in a normal process such as the body's immune system."


'"/>

Source:Ludwig Institute for Cancer Research


Page: 1

Related biology news :

1. Gene variations explain drug dose required to control seizures
2. B cells are required for development of epithelial cancer associated with chronic inflammation
3. Malignant melanoma cells secrete protein required for embryo formation
4. New study reveals signaling pathways required for expansion of pancreas stem cells
5. Fox Chase Cancer Center scientists identify immune-system mutation
6. Genetically modified natural killer immune cells attack, kill leukemia cells
7. Studies reveal methods viruses use to sidestep immune system
8. Jumping gene helps explain immune systems abilities
9. Scientists solve structure of key protein in innate immune response
10. Rats infected as newborns grew up vulnerable to memory problems during an immune challenge
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... QC , April 20, 2017 /PRNewswire/ - Prometic Life Sciences ... presented new results at the International Liver Congress ("ILC") 2017 ... ("EASL") in Amsterdam on the positive ... a mouse model of obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President ...
(Date:4/20/2017)... , ... April 20, 2017 , ... ... of a unique intellectual property (IP) sharing and commercialization model. , The Center ... inventions. A main component of this effort is bringing the IP to the ...
(Date:4/20/2017)... 20, 2017 For today, Stock-Callers.com redirects ... drug development and clinical research aimed at treating diseases and ... BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: ... You can access our complimentary research reports on these stocks ... http://stock-callers.com/registration ...
(Date:4/19/2017)... , ... April 18, 2017 , ... Alisa Wright, founder ... Alumni Awards from the Purdue College of Pharmacy in Lafayette, Indiana. , The ... Program for achievements in their careers and other scientific endeavors. , Wright began ...
Breaking Biology Technology: